In the BioHarmony Drug Report Database
Gadoxetate
Eovist (gadoxetate) is a small molecule pharmaceutical. Gadoxetate was first approved as Eovist on 2008-07-03. Eovist’s patent is valid until 2021-11-13 (FDA).
Trade Name
|
Eovist |
|---|---|
Common Name
|
gadoxetate |
ChEMBL ID
|
CHEMBL1201768 |
Indication
|
|
Drug Class
|
Image (chem structure or protein)